
November 18, 2025
BRC November 2025 Newsletter
View BRC November 2025 Newsletter November 2025 Newsletter

November 18, 2025
View BRC November 2025 Newsletter November 2025 Newsletter

August 14, 2025
View BRC August 2025 Newsletter August 2025 Newsletter

May 5, 2025
View BRC May 2025 Newsletter May 2025 Newsletter

January 23, 2025
View BRC January 2025 Newsletter

October 31, 2024
November 2024 Newsletter

August 2, 2024
August 2024 Newsletter

May 28, 2024
May 2024 Newsletter

February 12, 2024
Dean’s Office will provide your proposal Crosstalk Between Coagulation and Inflammation in Coronavirus Infection with Boost funding. The Boost award will provide $25,000 to help sustain current project and obtain preliminary data during the resubmission and review process. Dr. Silvio Antoniak received a UNC School of Medicine Boost Grant to further investigate the recently in …
February 12, 2024
Dean’s Office will provide proposal Regulation of Coagulation and Thrombosis by C1 Inhibitor with Boost funding. The Boost award will provide $22,771 to help sustain your project and obtain preliminary data during the resubmission and review process.

February 9, 2024
Notice of Award for a new R01 focused on the role of fibrinogen in thrombosis. The title is: “Novel mechanisms to limit thrombosis by decreasing fibrinogen or suppressing fibrin matrix formation”. The total funds for this award are: $2.9 million. Drs. Rafal Pawlinski and Wolfgang Bergmeier from the BRC are co-investigators.

February 8, 2024
Nature Cardiovascular Medicine publication written with our Duke colleague Dr. Ammon Fager. Title – Stopping the bleed when platelets don’t stick Journal – Nature Cardiovascular Research DOI – 10.1038/s44161-024-00421-3 View and download PDF

February 7, 2024
New MPI R01 awarded in the amount of $720,846 from the NIH National Heart, Lung, and Blood Institute (NHLBI) project title: Mechanisms of venous thrombosis and renal dysfunction in sickle trait. Abstract: This proposal will use both human blood samples from subjects who are carriers of the sickle cell gene (so-called ‘sickle cell trait’ or …